WELLS FARGO & COMPANY/MN
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,661,330
+$1,279,510 QoQ
Shares Held
68,650
+195.8% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 193 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. GLUE ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in GLUE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,661,330 | 68,650 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $381,820 | 23,211 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $824,579 | 52,588 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $268,833 | 36,280 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $151,972 | 33,697 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $132,494 | 28,555 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $486,923 | 70,162 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $117,712 | 22,210 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $60,991 | 16,308 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $93,193 | 13,219 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $67,138 | 11,883 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $46,730 | 9,756 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $93,502 | 13,650 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $42,976 | 5,517 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $653 | 80 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,446 | 253 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $220,730 | 15,744 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $322,227 | 15,780 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,269 | 57 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||